Genomic Intelligence for Genetic Disease & Cancer

Transforming Complex Genetic Data into Actionable Insights

Webinar | FEB 28 | The End of VUS?
Impact on Diagnosis and Treatment of Rare Diseases

Precision Medicine

Partner with us to get genomic intelligence to support development of genetic disease and cancer therapeutics


Explore Solutions
Clinical Diagnostics

Accelerate NGS variant interpretation with comprehensive search and insight into the full text of the genomic literature with Mastermind


Explore Software

INTRODUCING MASTERMIND 3.0


Mastermind’s new Gene Information Page puts comprehensive gene information and ACMG gene-wide parameters for interpretation of variants in large panels/whole exomes/genomes at your fingertips, so you can find the answers you need from just one platform.

Genomenon Awarded by Frost & Sullivan

Genomenon was awarded the 2023 Global Technology Innovation Leadership Award

Integrating Mastermind within our interpretation platform helps our users minimize the manual effort it takes to select and read relevant evidence-based papers.


Martin Reese, President & CEO, Fabric Genomics
Martin Reese, President & CEO, Fabric Genomics

Using Mastermind enhances our ability to provide clinicians at the bedside with important relevant information about known treatments and interventions.


Dr. Stephen Kingsmore, President and CEO, Rady Children’s Institute for Genomic Medicine
Dr. Stephen Kingsmore, President and CEO, Rady Children’s Institute for Genomic Medicine

Mastermind’s Supplemental data feature directly benefits my quality of life as a Variant Scientist.


Daniel Miller, Medpace Reference Laboratories
Daniel Miller, Medpace Reference Laboratories

I can say with certainty that without the findings obtained from Genomenon, I would not have been able to provide a diagnosis for this patient.


Lipika Ray, PhD, Rare Genomics Institute
Lipika Ray, PhD, Rare Genomics Institute

Genomenon’s methodology improved the efficiency and completeness of our literature review process.


Vice President, Translational Research & Development, Rare Pharmaceutical Company
Vice President, Translational Research & Development, Rare Pharmaceutical Company

I don’t consider a patient’s report complete unless every variant has been researched through Mastermind


Dr. Nikoletta Sidiropoulos, Medical Director of Genomic Medicine, University of Vermont Health Network
Dr. Nikoletta Sidiropoulos, Medical Director of Genomic Medicine, University of Vermont Health Network

Mastermind is the most exhaustive genomic knowledge base in existence, built by indexing nearly seven million full-text genomic articles and 500,000 supplemental data sets.


Bio-IT World
Bio-IT World

(Searching Mastermind by phenotype) will be invaluable in our ongoing work to diagnose and treat babies with rare diseases.


Shareef Nahas, Senior Director, Clinical Operations, Rady Children's Institute for Genomic Medicine
Shareef Nahas, Senior Director, Clinical Operations, Rady Children’s Institute for Genomic Medicine